Obstetrics & gynecology
Women’s health & pregnancy clinical trials
Reproductive health, pregnancy, and conditions specific to women. We’re tracking 6,323 recruiting studies in this area right now.
By phase
- Not applicable4,388
- Phase 2609
- Phase 1412
- Phase 3321
- Phase 4269
- Phase 1/Phase 2254
- Phase 2/Phase 370
Top conditions
- Ovarian Cancer338
- Cervical Cancer232
- Endometrial Cancer206
- Bladder Cancer190
- Acute Kidney Injury136
- Endometriosis135
- Pregnancy132
- Chronic Kidney Diseases131
- Breast Cancer107
- Chronic Kidney Disease104
- Infertility94
- Renal Cell Carcinoma80
- Colorectal Cancer74
- Preeclampsia73
- Pregnancy Related72
- Prostate Cancer65
- Pregnancy Complications63
- Urinary Incontinence63
Leading sponsors
- Mayo Clinic58
- Fondazione Policlinico Universitario Agostino Gemelli IRCCS48
- Assistance Publique - Hôpitaux de Paris47
- IRCCS Azienda Ospedaliero-Universitaria di Bologna47
- M.D. Anderson Cancer Center45
- National Cancer Institute (NCI)40
- University of Colorado, Denver39
- Chinese University of Hong Kong38
- University of Aarhus36
- AstraZeneca34
Where studies are running
- California345
- Alabama155
- Texas121
- Massachusetts119
- New York118
- Florida103
- Arizona100
- Colorado90
- Maryland90
- Illinois78
Recruiting studies6,323 total
- NCT04235764Recruiting
Testing a new bladder-tumor surgery tool for removed tissue
This trial studies a redesigned surgical instrument used during bladder tumor removal, to see if it can improve how the removed tissue samples are collected. It may help future patients by supporting better study of bladder tissue during cancer care.
Bethesda, MarylandAges 18–120 - NCT04240054RecruitingPhase 2
Study drugs before transplant for myeloma with kidney problems
This Phase 2 trial tests whether a combination of anti-myeloma medicines given before stem cell transplant works well and is safe for people with multiple myeloma who also have kidney problems. It may help control the myeloma and prepare you for the transplant.
Milwaukee, WisconsinAges 18 years+ - NCT04242069Recruiting
Lifestyle coaching for overweight women trying to conceive
This trial tests a lifestyle program (using a smartphone) to help overweight women improve health before pregnancy while trying to conceive within the next year. It may help you and your partner build healthy habits before pregnancy.
Québec, QuebecAges 18–40 - NCT04248283Recruiting
Adjustable continence therapy for stress urine leakage
This trial tests an adjustable treatment to reduce stress urinary incontinence (urine leaking when you cough, sneeze, or exercise). It’s for women who still leak after trying other treatments and who may be able to have surgery, while excluding certain bladder problems and health risks.
Denver, ColoradoAges 22 years+ - NCT04258449Recruiting
Testing a new uterine sampling tool during surgery
This trial tests a new device that takes small samples from the uterus during surgery for suspected or confirmed upper reproductive tract cancer. It may help doctors collect better tissue samples safely while you are already having surgery for tumor removal.
Montreal, QuebecAges 18 years+ - NCT04263922RecruitingPhase 4
Huaiqihuang granules for kidney inflammation in CKD stage 3
This trial studies whether Huaiqihuang granules can improve primary glomerulonephritis (a kidney inflammation) in people with chronic kidney disease at stage 3. It may help control kidney-related measures and reduce progression, compared with standard care.
Beijing, Beijing MunicipalityAges 18–65 - NCT04264065Recruiting
Albumin study in severe burn patients in ICU
This trial looks at whether giving or measuring albumin (a blood protein) can help predict outcomes for people with very severe burns in the ICU. It may help doctors understand who is at higher risk and guide care during the first day after injury.
Paris, FranceAges 18–80 - NCT04270578Recruiting
Study of gestational diabetes during pregnancy and after birth
This trial looks at gestational diabetes (high blood sugar during pregnancy) and may study how it’s managed during pregnancy and postpartum. It may help researchers understand what approaches are safe and useful for people with this condition.
TübingenAges 18 years+ - NCT04273061RecruitingPhase 2
Atezolizumab for tumors that look sensitive on DNA/RNA testing
This Phase 2 study tests atezolizumab, an immunotherapy drug, in people with advanced, incurable solid tumors whose tumor DNA/RNA suggests they may respond. The goal is to see if the treatment works better for patients selected by these lab results.
Vancouver, British ColumbiaAges 18 years+ - NCT04279457RecruitingPhase 4
Test whether special dye helps protect kidney function during heart procedures
This trial studies whether a device called Dye-Vert Plus can lower the risk of kidney injury from contrast dye during heart catheter procedures (CAG and/or PCI). It focuses on people at higher kidney risk, especially those with diabetes or high blood pressure.
Charleston, West VirginiaAges 18–90 - NCT04282044RecruitingPhase 1
CRX100 drug trial for advanced cancers with or without pembrolizumab
This Phase 1 trial tests CRX100 (a new cancer medicine) alone and with pembrolizumab (an immune checkpoint drug) in people with advanced solid tumors. It’s mainly designed to check safety and side effects, and to see whether tumors respond, potentially helping people whose cancer has come back or stopped responding to standard treatment.
Scottsdale, ArizonaAges 18 years+ - NCT04282356RecruitingPhase 2
Test of strong chemotherapy delivered inside the abdomen
This Phase 2 trial tests an intensive treatment for advanced ovarian, fallopian tube, or primary peritoneal cancer. It combines planned surgery to remove visible tumor with chemotherapy that is put directly inside the abdomen during the operation, aiming to control the cancer more effectively.
MontpellierAges 18–75 - NCT04284969Recruiting
Study of surgery plan for advanced ovarian or peritoneal cancer
This trial looks at whether a specific treatment pathway that may include surgery helps people with advanced ovarian (or related) cancer. It mainly involves planning and undergoing a complex pelvic surgery, sometimes after chemotherapy, to improve outcomes.
BordeauxAges 70 years+ - NCT04288427Recruiting
Testing a prostate marker to predict response to finasteride
This study looks at a prostate test marker to understand who is more likely to benefit from 5-ARI medicines such as finasteride or dutasteride. If you have enlarged prostate symptoms and are getting a biopsy, the results may help doctors better choose or interpret 5-ARI treatment.
Boston, MassachusettsAges 50 years+ - NCT04291768RecruitingPhase 4
Shorter 5-day antibiotics for certain gram-negative bloodstream infections
This trial tests whether people with a specific type of bloodstream infection caused by gram-negative bacteria can safely take antibiotics for only 5 days instead of longer. It may help by reducing antibiotic exposure if your infection source is controlled quickly.
AalborgAges 18 years+ - NCT04294368Recruiting
Fortifying donor breast milk for very premature babies
This study tests whether adding extra nutrition (fortifying) to donated breast milk helps very premature infants grow better and safely. You might be offered a fortified donor milk feeding plan if your baby meets the timing and medical criteria.
New York, New YorkAges 1 day–3 weeks - NCT04294927Recruiting
Tube removal first, then ovaries later for high-risk women
This study looks at whether removing the fallopian tubes first, and the ovaries later, is safe for women with certain inherited gene mutations that raise ovarian cancer risk. It may help you understand a prevention approach when you’re considered high risk and have finished having children.
Chicago, IllinoisAges 25–50 - NCT04299646RecruitingPhase 2
Stereotactic radiation for limited spread in kidney cancer
This trial tests whether targeted, high-precision radiation (stereotactic radiotherapy) can control a small number of growing kidney cancer metastases while you continue systemic treatment. It may help people who have “oligoprogressive” disease, where only 1–3 spots are getting worse.
AlbiAges 18 years+ - NCT04300556RecruitingPhase 1/Phase 2
Testing an antibody-drug for advanced certain cancers
This early-phase trial tests a treatment called MORAb-202, an antibody “delivery” drug, to see if it’s safe and can help shrink or control certain advanced cancers. It may help people whose tumors match the study’s specific cancer types and prior treatment history.
Tucson, ArizonaAges 18 years+ - NCT04304846Recruiting
Follow-up program for very preterm babies at age 3
This trial is part of a regional follow-up program for babies born very early. It looks at how these “extremely preterm” children do as they grow, and can help the care team spot needs earlier at the age-3 visit.
AngersAges 3–6 - NCT04304625RecruitingPhase 3
Tranexamic acid to reduce blood loss after C-section
This trial studies whether tranexamic acid can prevent heavy bleeding after a planned or urgent cesarean delivery in people with placenta previa. If you qualify, you may receive the study drug to help your body keep blood loss lower during and after surgery.
BordeauxAges 18–65 - NCT04303702Recruiting
Oxytocin during late labor to study childbirth changes
This study looks at how oxytocin, a medication that helps labor contractions, affects the second stage of labor. It may help researchers understand what leads to safer and smoother delivery for first-time mothers.
St Louis, MissouriAges Any age - NCT04305743RecruitingPhase 4
Compare pain after 5 vs 20 bladder botox injections
This study looks at how much discomfort you have after receiving bladder Botox injections, comparing a smaller (5) dose vs a larger (20) dose. It’s only for certain overactive bladder conditions and specifically when the procedure is done without sedation or special anesthesia.
Washington D.C., District of ColumbiaAges 18 years+ - NCT04305808Recruiting
Study of gut, bladder, and vaginal bacteria in recurrent UTIs
This study looks at the bacteria living in the vagina, urine tract, and stool to learn why some women get repeated urinary tract infections (UTIs). The results may help doctors better prevent or treat UTIs in the future.
Jerusalem, JerusalemAges Any age
Common questions
- How many women’s health & pregnancy clinical trials are recruiting?
- Clin2 is tracking 6,323 recruiting obstetrics & gynecology studies from the U.S. registry right now, out of 10,263 we cover in this area in total.
- What does “Women’s health & pregnancy” cover here?
- Reproductive health, pregnancy, and conditions specific to women. We group each study into women’s health & pregnancy based on the conditions it studies, so you can scan the whole therapeutic area at once and drill into a specific condition.
- How do I find a women’s health & pregnancy trial near me?
- Use the search to filter women’s health & pregnancy studies by location and eligibility. Every Clin2 trial page explains the criteria in plain English and offers a short, optional pre-screen for a fit read — the study team makes the final decision.
Other specialties
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov; specialty groupings are derived from each study’s conditions. Talk with your doctor about whether a specific trial is right for you.